Squarepoint Ops LLC Sells 57,072 Shares of Amrize Ltd $AMRZ

Key Points

• Squarepoint Ops cut its Amrize stake by 55.2% in the second quarter, selling 57,072 shares and retaining 46,349 shares valued at approximately $2.47 million.
• Amrize shares opened at $39.50, near their one-year low of $39.42, after the company missed quarterly EPS estimates ($0.88 versus $0.92 expected). The stock has an average analyst rating of “Hold” and a consensus price target of $55.50.
• Despite institutional selling, Amrize insiders purchased 48,983 shares worth about $2.16 million over the past 90 days, while new institutional positions included a roughly $929 million investment from Norges Bank.

Squarepoint Ops LLC decreased its stake in shares of Amrize Ltd (NYSE:AMRZ - Free Report) by 55.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,349 shares of the company's stock after selling 57,072 shares during the quarter. Squarepoint Ops LLC's holdings in Amrize were worth $2,470,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Gulf International Bank UK Ltd bought a new position in Amrize in the 4th quarter valued at approximately $1,219,000. HighTower Advisors LLC purchased a new stake in shares of Amrize during the 4th quarter valued at about $1,516,000. Norges Bank bought a new position in Amrize in the fourth quarter worth approximately $929,333,000. Ilmarinen Mutual Pension Insurance Co purchased a new position in shares of Amrize during the 4th quarter valued at about $3,569,000. Finally, Engle Capital Management L.P. purchased a new stake in Amrize in the 1st quarter worth $3,742,000.

Insider Activity at Amrize

In related news, CEO Jan Jenisch purchased 4,000 shares of the company's stock in a transaction dated Wednesday, September 2nd. The stock was acquired at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the transaction, the chief executive officer directly owned 519,000 shares of the company's stock, valued at approximately $22,057,500. This trade represents a 0.78% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mario Gross acquired 3,568 shares of Amrize stock in a transaction that occurred on Tuesday, August 11th. The shares were bought at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the transaction, the insider owned 38,485 shares of the company's stock, valued at $1,793,401. This represents a 10.22% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought 48,983 shares of company stock worth $2,158,755 in the last 90 days. 0.54% of the stock is owned by insiders.

Amrize Stock Down 2.5%

NYSE AMRZ opened at $39.50 on Tuesday. The business has a fifty day moving average price of $46.94 and a 200 day moving average price of $52.27. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The company has a market cap of $21.85 billion, a P/E ratio of 18.20, a P/E/G ratio of 1.20 and a beta of 0.04. Amrize Ltd has a one year low of $39.42 and a one year high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The business had revenue of $3.49 billion for the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. Research analysts anticipate that Amrize Ltd will post 2.67 EPS for the current fiscal year.

Amrize Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were paid a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize's dividend payout ratio is currently 20.28%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AMRZ. Sanford C. Bernstein reiterated an "outperform" rating on shares of Amrize in a research report on Monday, June 22nd. Citigroup downgraded shares of Amrize from a "buy" rating to a "cautious" rating in a research note on Wednesday, September 9th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Amrize in a report on Friday, June 26th. Wells Fargo & Company reissued an "equal weight" rating and issued a $44.00 price objective (down from $55.00) on shares of Amrize in a report on Wednesday, September 9th. Finally, Weiss Ratings cut shares of Amrize from a "hold (c)" rating to a "hold (c-)" rating in a research note on Monday, August 31st. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have assigned a Hold rating and four have given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $55.50.

Amrize Profile

Amrize is a North American building materials and solutions company formed through the separation of Holcim's North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.